WASHINGTON, DC
4 risk indicators measuring financial stability and operational resilience
Sign in with your work email to view Tuckman-Chang indicators
Sign In — Free (10 views/day)THE MESOTHELIOMA APPLIED RESEARCH FOUNDATION INC, founded in 1999, is a community nonprofit in the Diseases & Disorders sector that reported $1.5M in total revenue in fiscal year 2023. Revenue decreased 9% compared to the prior year. Net assets of $9.4M represent 73 months of operating reserves.
THE MESOTHELIOMA APPLIED RESEARCH FOUNDATION, INC. MISSION IS TO OFFER HOPE AND SUPPORT TO PATIENTS AND FAMILIES DEALING WITH MESOTHELIOMA. THIS IS ACCOMPLISHED BY EDUCATING PATIENTS AND FAMILIES ABOUT THE DISEASE, HELPING THEM OBTAIN THE MOST UP-TO-DATE INFORMATION ON TREATMENT OPTIONS, CONNECTING THEM WITH MESOTHELIOMA TREATMENT SPECIALISTS, AND PROVIDING ASSISTANCE, EMOTIONAL SUPPORT, AND COMMUNITY WITH OTHERS. THE FOUNDATION PROVIDES FUNDING TO THE HIGHEST QUALITY AND MOST PROMISING MESOTHELIOMA RESEARCH PROJECTS WORLDWIDE THROUGH RIGOROUS PEER-REVIEW. THE FOUNDATION ALSO WORKS TO RAISE AWAREMESS OF THE DISEASE, AND ADVOCATES THAT THE PUBLIC AND PRIVATE SECTORS PARTNER IN THE EFFORT TO CURE IT BY DIRECTING THE RESOURCES NEEDED TO STOP THIS GLOBAL TRAGEDY.
EDUCATION SUPPORT AND SYMPOSIUM - PATIENT SUPPORT SERVICES OFFERED BY THE MESOTHELIOMA APPLIED RESEARCH FOUNDATION, INC. INCLUDE PERSONALIZED CONSULTATIONS AND GUIDANCE THROUGH TREATMENT WITH...
EDUCATION SUPPORT AND SYMPOSIUM - PATIENT SUPPORT SERVICES OFFERED BY THE MESOTHELIOMA APPLIED RESEARCH FOUNDATION, INC. INCLUDE PERSONALIZED CONSULTATIONS AND GUIDANCE THROUGH TREATMENT WITH MESOTHELIOMA EXPERTS. THIS INCLUDES PROVIDING PATIENTS WITH INFORMATION ABOUT TREATMENT OPTIONS, CONNECTING THEM WITH MESOTHELIOMA TREATMENT SPECIALISTS WHEN NEEDED, AND FACILITATING ACCESS TO THE FOUNDATION'S SUPPORT GROUPS.
RESEARCH - THE MESOTHELIOMA APPLIED RESEARCH FOUNDATION, INC. FUNDS THE MOST PROMISING MESOTHELIOMA RESEARCH PROJECTS GLOBALLY, AS DETERMINED BY A RIGOROUS PEER-REVIEW PROCESS VIA THE FOUNDATION'S...
RESEARCH - THE MESOTHELIOMA APPLIED RESEARCH FOUNDATION, INC. FUNDS THE MOST PROMISING MESOTHELIOMA RESEARCH PROJECTS GLOBALLY, AS DETERMINED BY A RIGOROUS PEER-REVIEW PROCESS VIA THE FOUNDATION'S SCIENCE ADVISORY BOARD AND APPROVED BY THE BOARD OF DIRECTORS. THIS PROCESS IS BASED UPON THE DEPARTMENT OF DEFENSE CDMRP. BASED UPON THE NATIONAL CANCER INSTITUTE, THE MESOTHELIOMA FOUNDATION HAS FUNDED 97 GRANTS, AWARDING $9.6 MILLION IN FUNDING RESEARCH GRANTS TO DATE.
ADVOCACY - THE MESOTHELIOMA APPLIED RESEARCH FOUNDATION, INC. ADVOCATES ON BEHALF OF ITS PATIENTS AND FAMILIES FOR INCREASED FUNDING OF MESOTHELIOMA RESEARCH THROUGH FEDERAL INVESTMENT.
Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency
Sign in to view Trantor Score and financial metrics
Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)
Sign In — Free (10 views/day)| 2023 | 2022 | Change | |
|---|---|---|---|
| Revenue | $1,546,869 | $1,693,216 | -0.1% |
| Expenses | $1,532,223 | $1,190,526 | +0.3% |
| Net Income | $14,646 | $502,690 | -1.0% |
Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics
Financial Distress Indicator
Liquidity & Cash Position
Sign in to view all financial metrics
Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics
Sign In| Name | Title | Hours/Week | Role | Reportable Comp | Other Comp | Total |
|---|---|---|---|---|---|---|
| MARJORIE G ZAUDERER MD MS FACP | CHAIR | 1.00 |
Officer
Director
|
$0 | $0 | $0 |
| DARCIENA ANDERSON CHRISTEL | TREASURER | 1.00 |
Officer
Director
|
$0 | $0 | $0 |
| R TAYLOR RIPLEY MD | SECRETARY | 1.00 |
Officer
Director
|
$0 | $0 | $0 |
| KEITH CENGEL MD PHD | DIRECTOR | 1.00 |
Director
|
$0 | $0 | $0 |
| JASON M FOSTER MD | DIRECTOR | 1.00 |
Director
|
$0 | $0 | $0 |
| AARON S MANSFIELD MD | DIRECTOR | 1.00 |
Director
|
$0 | $0 | $0 |
| SANJAY POPAT PHD | DIRECTOR | 1.00 |
Director
|
$0 | $0 | $0 |
| BORIS SEPESI MD | DIRECTOR | 1.00 |
Director
|
$0 | $0 | $0 |
| DANIEL STERMAN MD | DIRECTOR | 1.00 |
Director
|
$0 | $0 | $0 |
| JAMES STEVENSON MD | DIRECTOR | 1.00 |
Director
|
$0 | $0 | $0 |
| WILLIAM N ZIEGLER | DIRECTOR | 1.00 |
Director
|
$0 | $0 | $0 |
| CHERYL BRUNER ESQ | DIRECTOR | 1.00 |
Director
|
$0 | $0 | $0 |
| JESSICA BLACKFORD-CLEETON | DIRECTOR | 1.00 |
Director
|
$0 | $0 | $0 |
| JULIE POWERS | EXECUTIVE DIRECTOR | 40.00 |
Officer
|
$120,056 | $5,670 | $125,726 |
| MAJA BELAMARIC | COO | 40.00 |
Officer
|
$134,162 | $7,095 | $141,257 |
| Year | Revenue | Expenses | Assets | Net Income |
|---|---|---|---|---|
| 2025 | No data | No data | No data | No data |
| 2024 | No data | No data | No data | No data |
| 2023 | $1,546,869 | $1,532,223 | $9,971,454 | $14,646 |
| 2022 | $1,693,216 | $1,190,526 | $9,449,879 | $502,690 |
| 2021 | $3,031,525 | $1,257,170 | $9,384,474 | $1,774,355 |
| 2020 | $5,570,526 | $1,070,432 | $7,513,333 | $4,500,094 |
| 2019 | $2,084,465 | $1,230,873 | $2,806,619 | $853,592 |
| 2018 | $1,269,294 | $1,480,319 | $1,950,261 | $-211,025 |
Compare THE MESOTHELIOMA APPLIED RESEARCH FOUNDATION INC with other nonprofits in District of Columbia and across the country.